Quick Takeaway
For people with Medicare, insulin costs remain capped in 2026—but there’s an important change many headlines miss.
For a one-month supply of each Part D-covered insulin product, your cost-sharing in 2026 is generally the lowest of:
- $35
- 25% of the Medicare-negotiated Maximum Fair Price, when applicable
- 25% of the plan’s negotiated price
The Part D deductible does not apply to covered insulin.
That means $35 is effectively a ceiling, not necessarily the amount everyone pays.
Some Medicare beneficiaries could pay less than $35 for certain covered insulin products in 2026.
Is the $35 Insulin Cap Actually New in 2026?
Not exactly.
Medicare’s insulin cost-sharing protection has already been in effect for several years.
What’s important about 2026 is that the calculation changes.
Previously, people often heard the rule summarized simply as:
“Medicare insulin costs no more than $35 per month.”
That’s still broadly useful.
But beginning in 2026, Medicare Part D uses the more favorable calculation described above.
CMS explicitly states that the applicable cost-sharing amount is the lesser of $35, 25% of the Maximum Fair Price, or 25% of the plan’s negotiated price for the covered insulin product.
So the better 2026 message is:
$35 or less.
How the 2026 Rule Works
Imagine your Medicare drug plan covers your insulin.
Scenario A
25% of negotiated price = $52
$35 cap = $35
You pay no more than $35.
Now consider another insulin.
Scenario B
25% of negotiated price = $28
$35 cap = $35
Your applicable cost sharing could be $28.
That’s the important 2026 distinction.
The rule doesn’t automatically force your copay to $35.
It prevents applicable cost sharing from exceeding the statutory limit.
What Medicare.gov Says
Medicare’s official consumer guidance states that beneficiaries pay no more than $35 for a one-month supply of each Part B- and Part D-covered insulin product, and the deductible doesn’t apply to insulin.
For a three-month supply, the maximum would generally be:
$35 × 3 = $105
for each covered insulin product.
Again, depending on the 2026 calculation, your actual cost could be lower.
Who Gets the Insulin Cost-Sharing Protection?
The protection primarily applies to Medicare beneficiaries whose insulin is covered through:
Medicare Part D
or qualifying insulin covered through:
Medicare Part B.
Which part of Medicare pays depends partly on how you receive your insulin.
Part D Insulin
Medicare Part D may cover insulin that is:
Injected using a pen
Injected using a needle
Inhaled
or:
Used with certain pumps that aren’t covered as durable medical equipment under Part B.
Medicare specifically notes that this can include certain disposable or patch pumps and some reusable pumps using disposable insulin cartridges.
For covered Part D insulin, the deductible doesn’t apply.
What About Insulin Pumps?
This is where Medicare coverage can become confusing.
If you use insulin through a qualifying durable insulin pump covered under:
Medicare Part B’s Durable Medical Equipment benefit,
Part B can cover the insulin used in that pump.
Medicare says the beneficiary’s cost for a month’s supply of Part B-covered insulin used with the qualifying pump can’t exceed:
$35
and the Part B deductible doesn’t apply to that insulin.
The Pump Itself Is Different
Don’t assume the $35 insulin cap means:
your entire insulin-pump system costs $35.
It doesn’t.
CMS explains that normal Medicare cost-sharing can still apply to:
The pump
Tubing
and:
Other supplies.
The insulin protection applies to the covered insulin—not necessarily every piece of equipment involved in insulin therapy.
What About Disposable Patch Pumps?
There’s another important distinction.
Medicare’s 2026 insulin guidance notes that some disposable or patch pumps themselves may cost more than $35 because:
the pump isn’t the insulin product.
Part D may cover insulin used with certain disposable pumps, but the cost-sharing protection for insulin shouldn’t be confused with the cost of the delivery device itself.
Does Every Insulin Qualify?
This is one of the most important limitations.
For Part D:
The insulin generally needs to be a covered insulin product under your plan.
That means consumers should check the plan’s:
Formulary — its covered-drug list.
A plan doesn’t necessarily have to cover every insulin product available in the United States.
So don’t interpret:
“Medicare has a $35 insulin cap”
as:
“I can buy any insulin I want for $35.”
Coverage still matters.
Check Your Exact Insulin Before Choosing a Plan
Suppose you use:
Insulin A.
Plan 1 covers it.
Plan 2 doesn’t.
Plan 2 may advertise:
“Insulin $35 or less.”
But that doesn’t necessarily help if your specific insulin isn’t covered.
Before choosing Medicare drug coverage, enter the exact:
Insulin name
Dosage
Quantity
and:
Pharmacy
into your plan comparison.
That’s much more reliable than comparing premiums alone.
Does the Deductible Apply to Insulin?
For covered insulin subject to these rules:
No.
CMS states that the Part D deductible doesn’t apply to covered insulin products.
This is particularly important because the standard Part D deductible in 2026 is:
$615.
Without the special insulin protection, someone needing insulin early in the year could otherwise face much higher upfront prescription expenses.
Example: January Prescription
Imagine your Part D plan has the standard:
$615 deductible.
You haven’t filled any prescriptions yet.
Then you refill your covered insulin in January.
You don’t first have to satisfy the entire $615 Part D deductible before receiving the insulin cost-sharing protection.
The insulin-specific rule applies.
That’s a major affordability protection for beneficiaries who need insulin every month.
What If You Use More Than One Insulin?
This is another detail that’s easy to miss.
The cost-sharing limit applies to a month’s supply of:
each covered insulin product.
Suppose someone uses two different covered insulin products.
If each reaches the maximum $35 amount, their total could hypothetically be:
$35 + $35 = $70 per month.
So don’t interpret the rule as:
“Nobody with Medicare can spend more than $35 total on insulin each month.”
It’s applied to each covered insulin product.
What About a 90-Day Supply?
Medicare explains that a three-month supply generally can’t cost more than:
$105
for each covered insulin product.
That’s:
$35 × 3 months.
If the applicable monthly cost is below $35, the corresponding extended-supply amount may also be lower.
What If I Have Extra Help?
The insulin protection also applies to people with Medicare Part D who receive Extra Help.
But some Extra Help beneficiaries may already qualify for cost sharing that’s:
below $35.
Medicare’s April 2026 insulin guidance explicitly says that beneficiaries receiving Extra Help may pay less than $35.
So again:
$35 is not necessarily your required copay.
Why 2026 Could Mean Less Than $35
This is one of the biggest updates consumers should understand.
Beginning in 2026, Part D insulin cost sharing considers:
25% of the Maximum Fair Price
for insulin subject to Medicare’s Drug Price Negotiation Program,
and:
25% of the plan’s negotiated price.
If either applicable calculation produces an amount below $35:
the lower amount can apply.
CMS describes the change as moving from a simple maximum copay framework to a calculation involving the lower applicable copayment or coinsurance amount.
Example: $100 Negotiated Price
Imagine your plan’s applicable negotiated price for a covered insulin is:
$100.
25% =
$25.
Because:
$25 < $35
the applicable statutory calculation could result in:
$25
rather than $35.
This simplified example shows why consumers shouldn’t automatically assume their 2026 insulin copay will always equal $35.
Example: $300 Negotiated Price
Now imagine the applicable negotiated price is:
$300.
25% =
$75.
Compare:
$75
with:
$35.
The lower figure is:
$35.
So the cost-sharing ceiling protects the beneficiary from the larger amount.
How the Medicare Drug Price Negotiation Program Fits In
2026 is also historically important because it’s the first year that negotiated prices for the first group of drugs selected under Medicare’s Drug Price Negotiation Program take effect.
CMS’s 2026 Part D rules integrate those Maximum Fair Prices into the insulin cost-sharing calculation when applicable.
That’s why the insulin rule is becoming slightly more complicated—but potentially more favorable for some beneficiaries.
The $2,100 Part D Out-of-Pocket Cap
Insulin users also benefit from another major Medicare Part D protection.
For 2026, the annual Part D out-of-pocket threshold is:
$2,100.
After reaching the applicable annual out-of-pocket threshold, enrollees enter the catastrophic phase, where they generally have no additional cost sharing for covered Part D drugs.
The 2025 limit was $2,000.
The 2026 amount increased to $2,100 under the statutory inflation adjustment.
Insulin Is Only One Part of Diabetes Spending
This distinction matters.
The insulin cost-sharing protection can substantially reduce insulin expenses.
But people with diabetes may also pay for:
Glucose testing supplies
Continuous glucose monitors
Needles
Syringes
Pump equipment
Doctor visits
Laboratory testing
and:
Other medications.
Those expenses don’t all automatically fall under the insulin-specific $35 protection.
Insulin Supplies Can Have Different Rules
For example, Medicare notes that Part D plans may cover certain supplies used to inject insulin, including:
Syringes
Needles
Gauze
and:
Alcohol swabs.
But the $35 insulin cap doesn’t simply make every diabetes-related item $35 or less.
Always distinguish:
the insulin
from:
the supplies used to administer it.
Continuous Glucose Monitors Are Separate
Continuous glucose monitors—or CGMs—have become increasingly common for diabetes management.
But CGMs aren’t insulin.
Their Medicare coverage and cost-sharing rules are separate from the insulin cap.
The same applies to many:
Test strips
Lancets
Meters
and:
Pump supplies.
This is why someone shouldn’t calculate their total diabetes budget based only on:
$35 × 12.
Your Pharmacy Still Matters
Part D plans use pharmacy networks.
Consumers should verify whether their preferred pharmacy is:
In network
and whether another pharmacy provides more favorable pricing for their other prescriptions.
The insulin cap provides important protection, but your pharmacy choice can still affect your broader prescription-drug spending.
Medicare Advantage Members Get Protection Too
If you receive prescription coverage through a:
Medicare Advantage Prescription Drug plan (MA-PD),
the Part D insulin cost-sharing protections apply to covered Part D insulin.
Medicare Advantage plans must follow applicable Medicare requirements.
However, the rest of your healthcare costs can differ substantially by plan.
So insulin cost shouldn’t be the only consideration when choosing Medicare Advantage coverage.
Don’t Choose a Plan Based Only on Insulin
Suppose:
Plan A
Covered insulin: $35
Premium: $0
but:
Your endocrinologist isn’t in network.
Plan B
Covered insulin: $30
Premium: $45
and:
Your endocrinologist and preferred hospital are in network.
Which plan is better?
There’s no universal answer.
You need to consider:
Total annual healthcare cost + provider access + drug coverage.
Compare All Your Medications
Someone with diabetes may also take medication for:
Blood pressure
Cholesterol
Heart disease
Kidney disease
or other conditions.
Your insulin may be inexpensive under both plans.
But another prescription could differ by:
hundreds or thousands of dollars annually.
That’s why Medicare plan comparison should include:
every medication you take.
What About the Medicare Prescription Payment Plan?
Medicare Part D plans also offer the:
Medicare Prescription Payment Plan.
This option allows participating beneficiaries to spread eligible out-of-pocket prescription costs across monthly payments during the year rather than paying the entire amount at the pharmacy at once.
However, this program:
doesn’t reduce the underlying prescription cost.
It changes the timing of payments.
For insulin users with other expensive medications, that may still help with monthly cash flow.
What the $35 Cap Doesn’t Mean
The insulin protection does not mean:
All diabetes care is $35 per month.
It does not mean:
Every insulin sold in America must be covered by your plan.
It does not mean:
Insulin pumps cost $35.
It does not mean:
Diabetes supplies are automatically free.
And it does not mean:
Everyone pays exactly $35.
For 2026, some Medicare beneficiaries may pay:
less.
2026 Example: A Medicare Beneficiary Using Insulin
Consider a hypothetical retiree named Robert.
Robert has:
Medicare Advantage with Part D.
He uses one covered insulin product.
His plan’s applicable 2026 calculation produces:
$35 per month.
His annual insulin cost would therefore be approximately:
$420
if he fills a one-month supply every month and nothing changes.
But Robert also uses:
Blood-pressure medication
Cholesterol medication
and:
Continuous glucose-monitor supplies.
Those items have separate coverage and cost-sharing rules.
So:
Robert’s insulin spending ≠ Robert’s total diabetes spending.
Another Example: Paying Less Than $35
Maria uses a covered Part D insulin.
Suppose 25% of the applicable negotiated price is:
$24.
Because the 2026 statutory calculation uses the lower applicable amount, Maria could pay:
$24
rather than $35 under this simplified example.
That’s why the phrase:
“$35 insulin cap”
is useful—but incomplete.
A more precise description for 2026 is:
“$35-or-less Medicare insulin cost sharing.”
Why This Matters for People on Fixed Incomes
Imagine someone previously faced unpredictable insulin expenses.
Predictability matters enormously when monthly income comes primarily from:
Social Security
Pensions
or:
retirement savings.
A predictable insulin ceiling makes it easier to budget.
For one covered insulin product at the full $35 monthly maximum:
Maximum annual cost = $420
for the insulin itself, assuming 12 one-month fills.
For two covered insulin products each reaching $35:
Maximum = $840
under that simplified scenario.
Again, other healthcare and diabetes-related costs remain separate.
How to Check Your Insulin Coverage
When reviewing a Medicare plan:
Step 1
Write down the exact name of every insulin you use.
Step 2
Check whether each product appears on the plan’s formulary.
Step 3
Confirm the expected 2026 cost.
Step 4
Enter all your other medications.
Step 5
Check your pharmacy.
Step 6
Compare the plan’s total estimated annual drug costs.
Step 7
For Medicare Advantage, also verify your doctors and hospitals.
Use the official Medicare Plan Finder to compare available coverage.
Questions to Ask Your Medicare Plan
If something isn’t clear, ask:
Is my exact insulin on your 2026 formulary?
What will I pay for a 30-day supply?
Would I pay less than $35 under the 2026 calculation?
What would a 90-day supply cost?
Which pharmacies are in network?
Do I need prior authorization?
Are there quantity limits?
What will my insulin-delivery supplies cost?
Getting answers before enrollment can prevent expensive surprises.
2026 Insulin Coverage Checklist
Before choosing or renewing Medicare coverage:
- List every insulin product you use.
- Confirm each insulin is covered.
- Check your expected monthly copay.
- Remember $35 is a ceiling for applicable covered insulin, not necessarily your exact cost.
- Check whether the 2026 calculation results in less than $35.
- Remember the Part D deductible doesn’t apply to covered insulin.
- Check 90-day supply pricing.
- Confirm your preferred pharmacy.
- Review insulin-supply costs separately.
- Review pump costs separately.
- Review CGM coverage separately.
- Enter all non-insulin prescriptions.
- Check the plan’s formulary restrictions.
- Review the $2,100 Part D annual out-of-pocket threshold.
- Compare total annual drug costs rather than insulin alone.
- For Medicare Advantage, verify doctors and hospitals.
- Review your coverage again each year.
Frequently Asked Questions
Is insulin capped at $35 in Medicare for 2026?
For a one-month supply of each covered insulin product, Medicare provides cost-sharing protections of $35 or less, depending on the applicable rules.
Can Medicare insulin cost less than $35 in 2026?
Yes. For Part D in 2026, the applicable amount is generally the lesser of $35, 25% of the applicable Maximum Fair Price, or 25% of the plan’s negotiated price.
Does the Part D deductible apply to insulin?
No. The Part D deductible doesn’t apply to covered insulin products subject to the insulin cost-sharing rules.
What’s the maximum for a three-month supply?
Medicare says a three-month supply generally costs no more than $105 for each covered insulin product, and it may be lower.
Does Medicare Part B cover insulin?
Part B covers insulin used with certain insulin pumps covered under Medicare’s Durable Medical Equipment benefit. The insulin cost for a month’s supply can’t exceed $35, and the Part B deductible doesn’t apply to that insulin.
Is an insulin pump limited to $35?
No. The $35 protection applies to covered insulin under the applicable rules. Normal Medicare cost-sharing can apply to the pump, tubing and other supplies.
What is the Medicare Part D out-of-pocket cap for 2026?
The annual Part D out-of-pocket threshold is $2,100 in 2026.
Final Thoughts
The biggest thing to understand about Medicare’s insulin rules in 2026 is:
$35 is a maximum—not necessarily your price.
For covered Part D insulin, the 2026 rules use the lower applicable amount among:
$35
25% of the Maximum Fair Price
or:
25% of the plan’s negotiated price.
The deductible also doesn’t apply to covered insulin.
That’s meaningful protection for millions of Medicare beneficiaries managing diabetes.
But insulin is only one part of the financial picture.
Your:
Formulary
Other prescriptions
Insulin supplies
Pump equipment
CGM
Doctors
and:
overall Medicare plan
can have just as much impact on your annual healthcare spending.
So when comparing plans for 2026, don’t simply ask:
“Does this plan have $35 insulin?”
Ask:
“What will my complete diabetes care actually cost under this plan?”
That’s the comparison that matters.